
Aclarion Raises $480,000 in Registered Direct Offering to Advance Chronic Low Back Pain Technology
Aclarion, a healthcare technology company, has announced a registered direct offering of common stock to raise approximately $480,000. The funds will be used to further develop and market their AI-driven technology for identifying the source of chronic low back pain.
Read full story




















